Efficacy, safety and biomarkers of SG001 for patients with previously treated recurrent or metastatic cervical cancer: an open-label, multicenter, phase Ib trial.

Jing ZuoWei DuanMingxuan ZhaoZhendong ChenJie LinHuaqiu ShiOu JiangYouzhong ZhangMeiyu FangLi WangWei WangYong HuangJunyan YuXiaoxue ZhangWeiqing PuDeshun HaoFenglin SheXiugao YangYing ChenQizhi TangXiao ZhangMiao NiuYan'e SongLing-Ying Wu

Published in: Cancer communications (London, England) (2024)

Keyphrases

squamous cell carcinoma
phase iii
small cell lung cancer
study protocol
clinical trial
phase ii
double blind
randomized controlled trial